Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

InVision Precision Cardiac Amyloid

K-Number: K243866 · 2025-05-21

Decision Date2025-05-21
Product CodeSDJ
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

InVision Precision Cardiac Amyloid is a medical device manufactured by InVision Medical Technology Corporation. It received FDA 510(k) clearance on 2025-05-21 under approval number K243866. The device is classified under product code SDJ. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the InVision Precision Cardiac Amyloid?

InVision Precision Cardiac Amyloid is a medical device that received FDA 510(k) clearance on 2025-05-21. It is manufactured by InVision Medical Technology Corporation. The 510(k) number is K243866.

When was InVision Precision Cardiac Amyloid approved by the FDA?

InVision Precision Cardiac Amyloid received FDA 510(k) clearance on 2025-05-21, under approval number K243866.

What company makes InVision Precision Cardiac Amyloid?

InVision Precision Cardiac Amyloid is manufactured by InVision Medical Technology Corporation.

What is the FDA product code for InVision Precision Cardiac Amyloid?

The FDA product code for InVision Precision Cardiac Amyloid is SDJ.

Related Clinical Trials

Other Devices by InVision Medical Technology Corporation

Related Devices (Code: SDJ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.